Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?

Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

1997 • 7,096 citations

C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women

2000 • 5,760 citations

Points of control in inflammation

2002 • 2,599 citations

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

1994 • 1,581 citations

Global burden of COPD: systematic review and meta-analysis

2006 • 1,447 citations

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

1992 • 1,341 citations

The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality

2005 • 1,205 citations

Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1

1994 • 1,119 citations

Body-Mass Index and Mortality in Korean Men and Women

2006 • 841 citations

Outcomes for COPD pharmacological trials: from lung function to biomarkers

2008 • 817 citations

Targeting C-reactive protein for the treatment of cardiovascular disease

2006 • 659 citations

Hospitalizations and Mortality in the Lung Health Study

2002 • 557 citations

Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD

2005 • 447 citations

Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease

2006 • 444 citations

Contemporary Management of Chronic Obstructive Pulmonary Disease

2003 • 413 citations

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease

2006 • 389 citations

The structure and biologic activities of plasma fibronectin

1980 • 385 citations

Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis.

2001 • 353 citations

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study

1992 • 343 citations

The structure and biologic activities of plasma fibronectin

1980 • 325 citations

Inflammatory Markers in SIRS, Sepsis and Septic Shock

2008 • 157 citations

Cigarette Smoke Inhibits Human Bronchial Epithelial Cell Repair Processes

2001 • 156 citations

Inflammation and Repair Processes in Chronic Obstructive Pulmonary Disease

1999 • 137 citations

Enhanced Bronchial Expression of Extracellular Matrix Proteins in Chronic Obstructive Pulmonary Disease

2006 • 127 citations

Binding of fibronectin by the acute phase reactant C-reactive protein.

1984 • 115 citations

C-reactive protein and atherothrombosis—Beyond a biomarker: an actual partaker of lesion formation

2003 • 114 citations

Fibronectin

1992 • 106 citations

Standardization of Immunoassays for Measurement of High-Sensitivity C-reactive Protein. Phase I: Evaluation of Secondary Reference Materials

2003 • 77 citations

Decreased Plasma Fibronectin Leads to Delayed Thrombus Growth in Injured Arterioles

2006 • 62 citations

Plasma fibronectin therapy and lung protein clearance with bacteremia after surgery

1987 • 28 citations

Plasma Fibronectin and Fibronectin Therapy in Sepsis and Critical Illness

1987 • 27 citations

Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins.

1996 • 26 citations

Association study between fibronectin and coronary heart disease

2005 • 25 citations

Emerging drugs for the treatment of chronic obstructive pulmonary disease

2006 • 21 citations

Effect of plasma fibronectin on the incisional wound healing in rats

2006 • 18 citations

Plasma fibronectin levels in meningococcal disease

1997 • 12 citations

Four immunoassay methods and standards compared for measuring fibronectin.

1987 • 9 citations

[Clinical significance of fibronectin and protease inhibitors in chronic obstructive pulmonary diseases].

1989 • 1 citations

[Molecular degradation forms of plasma fibronectin in patients with chronic obstructive pulmonary disease].

1994 • 1 citations